Globus Medical Reports Q3 Results, Adds $500 Million to Buyback Program
Globus Medical reported third-quarter revenue of $764 million, down slightly, and announced a $500 million increase to its share repurchase program.
AUDUBON, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. NYSE:GMED, a leading musculoskeletal technology company, today announced its financial results for the third quarter ended September 30, 2026.Third Quarter 2026 Results“Third quarter revenue finished at $764 million, down slightly…